E CM (extracellular matrix) degradation and remodeling is a hallmark of aortic aneurysm formation. The precise mechanisms behind the degradation of ECM components and subsequent dissection of the vessel wall are not completely elucidated. Histologically, diseased aortas present with variable degrees of ECM degeneration within the aortic medial layer, including cystic medial degeneration, elastic fiber fragmentation, and myxomatous degeneration. At the molecular level, aortic degeneration has been associated with vascular smooth muscle cell (SMC) apoptosis 1 and inflammation.
CM (extracellular matrix) degradation and remodeling is a hallmark of aortic aneurysm formation. The precise mechanisms behind the degradation of ECM components and subsequent dissection of the vessel wall are not completely elucidated. Histologically, diseased aortas present with variable degrees of ECM degeneration within the aortic medial layer, including cystic medial degeneration, elastic fiber fragmentation, and myxomatous degeneration. At the molecular level, aortic degeneration has been associated with vascular smooth muscle cell (SMC) apoptosis 1 and inflammation. 2 Factors that contribute to aortic wall degeneration both in humans and in animal models include AngII (angiotensin II), 3 TGF-β transforming growth factor-β), 4 and MMPs (matrix metalloproteinases). 5 The role of MMPs in the alteration of aortic ECM architecture has been extensively studied in the context of aortic aneurysm development. 5, 6 More recently, a family of metalloproteases known as ADAMTSs (a disintegrin and metalloprotease with thrombospondin motifs) has been explored in vascular ECM turnover. In particular, ADAMTS-1, -4, and -5 activities have been implicated in thoracic aortic aneurysm (TAA) formation. 3, 7, 8 ADAMTS-1, -4, and -5 are the main enzymes responsible for large aggregating proteoglycan cleavage. 9, 10 We have previously demonstrated that ADAMTS-5 is reduced in aortas of apolipoprotein E-null mice and that ADAMTS-5 activity affects proteoglycan-mediated lipoprotein retention. 11 We have also shown that on stent-induced vascular injury, a reduction in ADAMTS-1 and ADAMTS-5 contributes to an increase in large aggregating proteoglycans, notably aggrecan and versican. 12 Similarly, the absence of ADAMTS-5 leads to
In the present article, we aim to characterize regional differences in ADAMTS expression in murine aortas and to explore aortic ECM changes in mice with loss of ADAMTS-5 activity. Because the ECM is an intricate protein network and alterations in proteolytic activity will induce secondary remodeling processes, we used our established proteomics approach for studying the vascular ECM. 15 
Materials and Methods
An expanded Materials and Methods section is available in the onlineonly Data Supplement. The data that support the findings of this study are available from the corresponding author on reasonable request.
Animal Experiments
All animal procedures were performed by authorized researchers in the Cardiovascular Division, King's College London. Housing and animal care was in accordance with the UK Animals (Scientific Procedures) Act 1986. Genotyping of Adamts5
Δcat and control (Adamts5 +/+ ) mice was performed as previously published. 11 For AngII infusion, osmotic mini-pumps (Alzet, model 1004) containing AngII (1.44 mg g −1 d −1 dissolved in saline) were implanted in 10-to 12-week-old male Adamts5
Δcat and Adamts5 +/+ mice derived from littermates of heterozygous breeders (JAX stock no. 005771, B6.129P2-Adamts5 tm1Dgen /J). Animals were euthanized after 4 weeks, and the entire aorta was excised and immediately washed in sterile PBS. The entire aorta was snap-frozen at −80°C for subsequent proteomic analysis. For gene expression analysis, aortic tissue was divided into anatomically defined regions using a scalpel under a dissecting microscope, followed by immediate storage at −80°C. Aortic diameter was monitored using ultrasound at day 0 (baseline) and after 27 days of AngII treatment using Vevo software version 1.7.
Mouse Echocardiography
Animals were anesthetized using 5% isoflurane mixed with 1 L/min of 100% oxygen for 45 seconds to 1 minute. Mice were then placed in a supine position on a heating pad with embedded ECG registration. On adequate induction, 1% to 1.5% isoflurane mixed with 1 L/ min 100% oxygen was used to maintain a steady state of sedation throughout the procedure. A rectal probe was inserted to continuously monitor the body temperature. Electrode gel was applied to the 4 paws, which were taped to the ECG electrodes. Two-dimensional echocardiographic images of cardiovascular anatomy were obtained by a single operator. Standard and modified parasternal long-axis, suprasternal, longitudinal abdominal, and transverse abdominal views were obtained using Visual Sonics Vevo 2100. Aortic root dimensions (aortic annulus, sinuses of Valsalva, and sinotubular junction) were measured in parasternal long-axis view. AsAo dimensions were measured during systole and diastole in suprasternal view where possible and modified parasternal long-axis view if suprasternal views were considered inadequate. Measurements were taken from leading edgeto-leading edge. Abdominal aorta measurements were made in the TA view. All measurements were performed offline (Vevo software version 1.7) by 2 consensus interpreters.
Blood Pressure Monitoring
The blood pressure was directly measured via an implantable radiotelemetry device. An average of 200 values were acquired every 5 minutes for 18 to 20 hours. Blood pressure was monitored using telemetry probes 2 days before mini-pump implantation and at days 5 and 27 of AngII infusion.
ECM Protein Extraction From Murine Aortas
Aortic samples were partially thawed and diced into smaller pieces to aid the removal of plasma contaminants and for the effective extraction of ECM proteins. 16, 17 ECM protein enrichment of aortic samples was performed using an adaptation of our previously published 3-step extraction method, involving sequential incubation with 0.5 mol/L NaCl for 2 hours, 0.08% sodium dodecyl sulfate (SDS) for 2 hours, and a final incubation with 4 mol/L guanidine hydrochloride (GuHCl) for 48 hours. After precipitation of GuHCl extracts, protein samples were enzymatically deglycosylated and subjected to in-solution trypsin digestion. Details are given in Online Methods in the online-only Data Supplement.
Proteomics Analysis of ECM Extracts
After deglycosylation (protocol details are provided in the Online Methods in the online-only Data Supplement), digested peptides were separated on a nanoflow liquid chromatography system, and GuHCl extracts were injected for liquid chromatography-tandem mass spectrometry analysis into a Q Exactive HF mass spectrometer (Thermo Fisher Scientific) for discovery proteomics. Acquisition was performed as previously described. 15 For targeted MS analysis, an isolation list was created for proteotypic peptides of mouse versican and GuHCl extracts were analyzed via parallel reaction monitoring mode on a Q Exactive HF mass spectrometer. Details are given in Online Methods in the online-only Data Supplement.
Total Protein Extraction From Murine Aortas
Mouse aortic samples were homogenized in the presence of 300 μL of tissue lysis buffer (0.152 g of Tris, 0.33 g of NaCl, 0.038 g of EGTA, 0.073 g of EDTA, 500 μL of Triton, and 250 μL of 20% SDS) at pH 7.4. Protein concentration was measured using BCA protein assay kit, and Western blots were performed following the protocol in the Online Methods in the online-only Data Supplement.
Cell Culture of Human Arterial SMCs
Samples of internal mammary artery were collected from patients undergoing bypass graft surgery at Leeds General Infirmary, conforming with the principles outlined in the Declaration of Helsinki. 
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Arterial SMCs were extracted and expanded using an explant technique. 18 SMCs were seeded into 6-well tissue culture plates. Twentyfour hours after seeding, cells were cultured in serum-free DMEM for 1 hour. Ten nanogram per milliliter of human TGF-β1 (R&D systems) was diluted in serum-free DMEM (1195-045; Gibco), and cells were treated for 24 hours. Changes in versican expression after stimulation were measured by real-time quantitative PCR using TaqMan assay for the corresponding human target. Major Resources Table is given in the online-only Data Supplement.
Quantitative Real-Time PCR
RNA extraction was performed using the miRNeasy Mini Kit (Qiagen) following the manufacturers' protocol. RNA concentration (Abs 260 nm) and purity (260/280) were measured in 1 μL of eluted RNA using spectrophotometry (NanoDrop ND-1000; Thermo Scientific). RNA integrity was evaluated using the Agilent Bioanalyzer System and considered acceptable if the RNA integrity number was >7. The RNA was then reverse transcribed using random hexamers with SuperScript VILO MasterMix (Invitrogen) according to manufacturers' protocol, with sample preparation being performed on a StarChill PCR rack to maintain low temperature. The reverse transcription product was diluted 1:15 to 1:25 using RNase-free water. TaqMan hydrolysis probes were used for quantitative PCR analysis. Data were analyzed using ViiA 7 software (Applied Biosystems). A minimum of 2 reference genes was used throughout the study, and stability of RNA isolation, reverse transcription, and quantitative PCR was determined by variability of and correlation between reference genes. Analysis of stability was also performed using geNorm, a commonly used algorithm for validation of reference gene stability based on the comparative cycle-to-threshold method. 19 Relative amounts of the targets were calculated using the 2 −∆∆Cq method, 20 with statistical analysis performed on ∆Cq values.
Immunofluorescence Staining in Murine AsAo
Murine aortas were fixed for 24 hours in 4% formaldehyde at room temperature. In brief, 3-μm sections were deparaffinized in xylene and rehydrated in graded ethanol. The slides were unmasked using hot sodium citrate buffer (pH 6.0), then permeabilized for 20 minutes in 0.1% Triton X-100. Sections were blocked with 10% serum at room temperature, before incubation with primary antibodies against LRP1 and α-smooth muscle actin or species-matched isotopes overnight at 4°C. After washes in PBST, sections were incubated for 1 hour at room temperature with the secondary antibody. Nuclei were stained using DAPI for 10 minutes. Sections were visualized under a Nikon spinning disk confocal microscope (KO.18), and images were acquired using NIS-elements 4.0 software. Scale bars are included in the images as indicated in the figure legends.
Transfection Experiments in Human Aortic SMCs
Human aortic SMCs were purchased from LONZA and cultured in SMC medium (cc-3183; LONZA) with 5% fetal bovine serum (LONZA). SMCs were seeded into 6-well tissue culture plates, and 24 hours after seeding, cells were transfected with 50 nmol/L of LRP1 siRNA (Dharmacon, M-004721-01-0005, targeted sequences: GCAAGAAGCCGGAGCAUGA, GAACAAACACACUGGCUAA, GCUAUGAGUUUAAGAAGUU, GCGCAUCGAUCUUCACAAA) by using lipofectamine 2000 (Thermo Fisher Scientific) according to the manufacturer's instructions. Nontargeting siRNA served as control (Dharmacon, D-001206-14-05, targeted sequences: UAAGGCUAUGAAGAGAUAC, AUGUAUUGGCCUGUAUUAG, AUGAACGUGAAUUGCUCAA, UGGUUUACAUGUCGACUAA). Cells were incubated for 6 hours in Opti-MEM (11058-021; Gibco) with lipofectamine and siRNAs. After removal of transfection medium, SMCs were incubated with SMC medium with 5% fetal bovine serum for 48 hours. Then, cells were cultured in serum-free SMC medium for 24 hours. Medium was collected for protein measurements. Cells were harvested for quantitative PCR and Western blot analyses. Major Resources Table is given in the online-only Data Supplement. Four milliliters of conditioned media was concentrated using 0.5 mL columns with 3 kDa filter (Amicon Ultra Centrifugal Filter Device; 3 KD). Five hundred milliliters of samples was added each time and centrifuged at 14 000g for 40 minutes at 4°C until the residual volume was around 30 μL. Samples were then washed twice using 500 μL of 0.1% SDS each time. Protein concentrates were then used for Western blots. After conditioned medium collection, cell layers were washed 3× with cold PBS to remove the residual medium. Cells were scraped off in cold PBS and spun for 1 minute at 15 000g. One hundred milliliters of 1× lysis buffer with 1:100 proteinase inhibitors, 25 mmol/L of EDTA was added to cell pellets. After resuspension, lysed cell pellets were vortexed and incubated for 20 minutes on ice. Protein concentration was measured using a BCA protein assay kit before Western blot analyses.
Immunofluorescence Staining in Human Aortic Specimen
Human aortic tissues were collected from patients undergoing AsAo replacement surgery at St. George's Hospital according to the local Research Ethics Committee (London, REC No 08/H0803/257). Aortic tissues were fixed in 10% formalin and then embedded with paraffin. For antigen retrieval, chondroitinase ABC was applied on 5 μm tissue sections for 2 hours at 37°C. After blocking with 10% fetal bovine serum for 1 hour, sections were coincubated with primary antibodies to full-length versican and versican neoepitope DPEAAE overnight at 4°C. Species-matched isotype IgGs were used as negative controls. The appropriate secondary antibody was used for 1 hour at room temperature. Nuclei were stained with DAPI (1:1000 dilution) for 5 minutes. The images were visualized with an inverted Nikon Spinning disc confocal unit and acquired using NIS-elements 4.0 software.
Statistical Analysis
GraphPad Prism software 7 was used for the analysis. For each experiment, Shapiro-Wilk normality test was applied to test the distribution of the data. If the data were not normally distributed, a nonparametric test was used. The appropriate tests and post hoc analysis were chosen according to the data distribution as specified in each figure legend. Data are represented as mean±SD. For proteomics, statistical analysis was not performed if a protein was undetectable in the majority of samples from both groups compared. This is denoted as not applicable. Data from discovery proteomics are presented as normalized total ion current. Data obtained from targeted proteomics are presented as peak area and adjusted according to the total ion intensity for each sample. The aortic diameters are represented as box and whisker plots, with 75th and 25th percentiles; bars represent maximum and minimum values. Differences were assessed using a 2-way ANOVA and Sidak post hoc test. For all statistical analysis, P<0.05 was deemed significant.
Results

ADAMTS Expression in the Murine Aorta
Transcript levels of Adamts5 were higher in the aortic arch compared with the other aortic regions, along with transcript levels of the large aggregating proteoglycans versican (Vcan) and aggrecan (Acan), 2 ADAMTS-5 substrates, which were most highly expressed in the arch. Expression of Tgfb1 and 2 and Tgfbr2 and 3 were also higher in the arch compared with the abdominal aorta. In contrast, Adamts1 and Adamts4 and hyaluronan and proteoglycan link protein 1 (Hapln1) showed lower transcript levels in the arch compared with other regions of the murine aorta (Figure 1 ).
domain of Adamts5 (Adamts5 Δcat
. 21 Hypertension was induced in Adamts5 +/+ and Adamts5 Δcat mice by AngII infusion for 4 weeks ( Figure I in the online-only Data Supplement). AngII treatment was associated with increased aortic dilatation in Adamts5
Δcat mice ( Figure 2A and 2B); significant differences compared with Adamts5 +/+ were observed both in the aortic root, in particular in the aortic annulus, and the AsAo. Notably, the increased aortic dilatation in Adamts5
Δcat mice occurred despite an attenuated rise in systolic and diastolic blood pressure after 27 days of AngII treatment ( Figure 2C ). The aortic phenotype and the blood pressure changes in Adamts5
Δcat mice bear a strong resemblance to the one recently described in mice with Adamts1 haploinsufficiency. 
Vascular Substrates of ADAMTS-1 and ADAMTS-5
To identify vascular substrates of ADAMTS-1 and ADAMTS-5, murine aortas were subjected to overnight incubation with either ADAMTS-1 or ADAMTS-5 (50 pmol L −1 mg −1 tissue at 37°C; Figure 3A ). Aortas incubated in buffer only served as control. The proteins released into the digestion buffer were separated by SDS-PAGE, subjected to in-gel tryptic digestion, and analyzed by liquid chromatographytandem mass spectrometry. Among the identified extracellular proteins, proteins with differential release on digestion by ADAMTS-1 and -5 include known substrates such as versican (CSPG2; Figure 3B ; Table I in the online-only Data Supplement). Detailed examination of the gel-liquid chromatography-tandem mass spectrometry data revealed the presence of proteolytic products ( Figure 3C ), that is, for CSPG2, CO6A6 (collagen type VI α-6), FINC (fibronectin), and LRP1. However, proteolytic cleavage may occur without differential release into the digestion buffer, that is, a higher number of MS/MS spectra for biglycan (PGS1) and COCA1 (collagen type XII α-1) were identified in-gel segments below the expected molecular weight of the full-length protein indicative of proteolysis. Again, this includes known substrates of ADAMTS-5, such as PGS1.
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Proteomics Analysis of Aortas From AngIITreated Wild-Type and Adamts5
Δcat Mice
To analyze the changes in ECM composition on loss of ADAMTS-5 activity, aortas from AngII-treated Adamts5
and Adamts5 Δcat mice were subjected to a 3-step sequential extraction procedure: pretreatment with 0.5 mol/L NaCl followed by decellularization with 0.08% SDS and a final incubation step with 4 mol/L GuHCl to solubilize the ECM ( Figure 4A ). Using a discovery proteomics approach, along with MFAP5 (microfibrillar-associated protein 5), Δcat mice ( Figure 4B ; Table II in the online-only Data Supplement). Subsequent targeted proteomics analysis using both N-terminal and C-terminal proteotypic peptides corroborated that versican was elevated in AngII-treated Adamts5
Δcat mice ( Figure 4C ; Table III in the online-only Data Supplement). TGF-β1 is known to enhance versican expression. 23 Human arterial SMCs stimulated with TGF-β1 showed a rise in versican transcripts ( Figure 4D ). Notably, higher levels of versican were associated with increased protein abundance of TGF-β in aortas of AngIItreated Adamts5 Δcat mice ( Figure 4E ; Figure +/+ and Adamts5 Δcat mice are represented using burgundy and purple color, respectively. C, Systolic and diastolic blood pressure measurements at day 0, 5, and after 27 days of AngII infusion in Adamts5 +/+ (n=6) and Adamts5 Δcat mice (n=4). Data points are mean±SD; P values derived from a 2-way ANOVA (aortic diameter) and 1-way ANOVA (blood pressure) with Sidak correction. *P<0.05, **P<0.01.
markedly elevated in Adamts5
Δcat mice, suggesting a compensatory increase of ADAMTS-1 on loss of ADAMTS-5 activity.
Versican Cleavage in Aortas of Adamts5
Versican was the most differentially regulated ECM protein in aortas from Adamts5 Δcat mice treated with AngII ( Figure 4B ). It was also returned as one of the major substrates of ADAMTS-1 and -5 in the analysis of aortic explants ( Figure 3B ). Therefore, we focused on ADAMTS-mediated versican processing. ADAMTS activity results in the release of a specific versican fragment ending with the DPEAAE 441 sequence, 11, 24 named versikine. 25 This signature cleavage site of ADAMTS activity can be detected using a neoepitope antibody ( Figure 5A ). As expected, aortas from Adamts5
Δcat mice displayed reduced versikine; the 65 kDa band is representative of versikine ( Figure 5B ). Even after AngII treatment, less versikine was observed in Adamts5
Δcat mice. This highlights the dependence on ADAMTS-5 activity for versicanolysis in AngII-induced aortic remodeling ( Figure 5C ).
Compensatory Increase of ADAMTS-1 in Aortas of Adamts5
Because of different processing, ADAMTS-1 can be found in 2 forms, a larger cell layer and ECM-associated version and a smaller, soluble version ( Figure 5A ). 26 Immunoblotting for ADAMTS-1 performed on total aortic tissue lysates revealed that the loss of ADAMTS-5 activity was accompanied by an increase in the smaller, soluble form of ADAMTS-1 (65 kDa). This was exacerbated after AngII treatment. In contrast, the larger, ECM-associated ADAMTS-1 form (79 kDa) was detected almost exclusively in the wild-type group. The increase in soluble ADAMTS-1 suggests a cross-talk between members of the ADAMTS protease family; however, this compensatory upregulation did not result in the complete rescue of ADAMTS-mediated versican cleavage ( Figure 5C ).
Reduced LRP1 in AngII-Treated Aortas of Adamts5
To further investigate the molecular mechanisms, associated with the loss of ADAMTS-5 activity, we analyzed LRP1, a receptor implicated in the endocytosis of ADAMTS proteases. LRP1 was identified as a vascular target of ADAMTS-1 and -5 ( Figure 3 ). LRP1 was profoundly reduced in aortas of AngIItreated Adamts5 Δcat mice ( Figure 5C ; Figure IV in the onlineonly Data Supplement). LRP1 staining was mainly observed in SMCs of mouse aortas ( Figure 6A ). Next, we silenced LRP1 expression in primary human aortic SMCs. Silencing LRP1 did not affect ADAMTS1 gene expression but markedly reduced expression of ADAMTS5 ( Figure 6B ). Consequently, ) proteins (55 proteins were tested by Kruskal-Willis test, and 13 were found differentially regulated; P<0.05) in the supernatants of mouse aortas as identified by proteomics (n=3). The blue-red heat map represents normalized spectral counts highlighting differences in proteins released from aortic explants. C, Spectral evidence for fragmentation. The color-coded heat map represents the total number of identified spectra in each gel band and visualizes the fragmentation of ECM proteins. Color scales for heat maps represent maximum and minimum number of spectra identified in each group. COCA1 indicates collagen type XII a1 chain; CO6A6, collagen type VI a6 chain; CSPG2, versican; FINC, fibronectin; LC-MS/MS, liquid chromatography-tandem mass spectrometry; LRP1, low-density lipoprotein receptor-related protein 1; and PGS1, biglycan. by guest on May 11, 2018 http://atvb.ahajournals.org/ Downloaded from versikine was barely detectable in the conditioned media of SMCs transfected with an siRNA to LRP1. Moreover, in agreement with our results in AngII-treated Adamts5
Δcat mice, we observed a concomitant increase in ADAMTS-1 on repression of LRP1 ( Figure 6C ; Figure V in the online-only Data Supplement). Thus, these in vitro experiments complement our in vivo findings and establish a link between LRP1 and ADAMTS-5-mediated versican cleavage.
Versican Cleavage in Human Aortic Aneurysms
Although differences in versican abundance have been reported in human abdominal aortic aneurysms, 27 versikine has not been localized yet in human AsAo aneurysms.
Immunofluorescence staining was performed for versican and versikine. Versican staining was seen throughout the aortic wall, whereas versikine was localized predominantly in the outer media and the subintimal layer of the AsAo aneurysm ( Figure 6D ). These data confirm the presence of ADAMTSspecific versican cleavage in human ascending TAA tissue.
Discussion
We have characterized regional differences in ADAMTS expression along the murine aorta and used proteomics to evaluate the effect of loss of ADAMTS-5 activity on aortic ECM remodeling. We demonstrated that deficiency of ADAMTS-5 affects ADAMTS-1 gene expression, protein abundance, and processing and resulted in aortic dilatation similar to the phenotype recently described in Adamts1-haploinsufficient mice. +/+ (a disintegrin and metalloproteinase with thrombospondin motifs; n=6) and Adamts5
Δcat (n=5) mice were analyzed using discovery proteomics. Black dots represent proteins differentially regulated between the groups (P<0.05). Statistical significance was calculated using Mann-Whitney test (76 ECM and ECM-associated proteins were tested, and 2 were found differentially regulated). C, Two different proteotypic peptides (ie, N terminal and C terminal) were chosen to validate levels of versican in aortic tissue using targeted proteomics. Peak area values of versican in Adamts5 +/+ served as reference for N-terminal and C-terminal peptides. Statistical significance was calculated using unpaired Student t test. D, Internal mammary artery smooth muscle cells (SMCs) from 4 donors were incubated with TGF (transforming growth factor)-β1. Gene expression of versican was assessed by quantitative PCR. Gapdh was used as internal control. Statistical significance was calculated using unpaired Student t test. E, Immunoblots performed on total protein lysates reveal an increase in full-length versican and TGF-β in aortas of AngII-treated Adamts5
Δcat mice (n=4 per group). CSPG2 denotes versican; GuHCl, guanidine hydrochloride; LC-MS/MS, liquid chromatography-tandem mass spectrometry; and MFAP5, microfibrillar-associated protein 5. 
ADAMTS Proteases in Murine Aortas
ADAMTS-1 and ADAMTS-5 are highly expressed in murine aortas. We have previously demonstrated that ADAMTS-5 is the most potent protease associated with versican cleavage in the murine aorta. 11 Loss of ADAMTS-5 also results in the accumulation of aggrecan. 12 To investigate the contribution of ADAMTS-5 in ECM remodeling during aortic aneurysm formation, a mouse model lacking ADAMTS-5 activity was used. Administration of AngII for 4 weeks exacerbated aortic dilatation in Adamts5
Δcat mice, with a significantly greater diameter in the AsAo where Adamts5 expression is the highest in
Adamts5
+/+ mice. Moreover, Adamts5 Δcat mice showed a lower blood pressure in response to AngII stimulation. Interestingly, a recent study reported a similar reduction in blood pressure in Adamts1-haploinsufficient mice.
3 Also other ADAMTS proteases have been implicated in the vasculature and the regulation of blood pressure.
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Proteomics to Identify Vascular Substrates
In the current study, we used proteomics for the analysis of aortic ECM changes associated with loss of ADAMTS-5 activity. By using proteomics, we found that versican was 65 kDa) . B, C, Immunoblots using neoepitope antibodies to versikine were performed on aortic ECM (extracellular matrix) extracts from untreated and AngII (angiotensin II)-treated mice (n=5 per group). Immunoblots for ADAMTS-1 and LRP1 (low-density lipoprotein-related protein 1) were performed on total protein lysates of untreated and AngII-treated mice (n=5 and n=4 per group, respectively). Densitometry for the versican V1 fragment (versikine) and ADAMTS-1. Bars represent mean±SD. Statistical significance was calculated using unpaired Student t tests. *P<0.05, **P<0.01.
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Δcat mice. Versican is one of the most abundant large aggregating proteoglycans in the aorta. 16 Tissue accumulation of versican has been linked to the loss of fibrous ECM organization. 29 Because we failed to detect changes in versican gene expression in Adamts5
Δcat mice (data not shown), differences in versican protein abundance are most probably related to post-translational processing rather than protein synthesis. Versican is a well-known substrate of ADAMTS proteases. 30 The release of versikine was also observed after incubation of human aortic tissues with either ADAMTS-1 or ADAMTS-5. 11 The absence of the catalytic activity of ADAMTS-5 seems to result in the buildup of unprocessed versican in the aortic wall, as previously observed in valve tissue of Adamts5
Δcat mice.
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ADAMTS-Mediated Versicanolysis
Versican can be cleaved by different proteases including MMPs, 31 plasmin, 32 and several members of the ADAMTS family. The latter harbor sequence motifs specific to large aggregating proteoglycans, including versican. 16 The neoepitope DPEAAE at position 441 of versican is generated after ADAMTS cleavage. 25 The neoepitope antibody recognizes only the cleaved product of versican, corresponding to the N terminus of the proteoglycan. 25 This fragment was reduced in Adamts5
Δcat mice, which is in agreement with our previous report. 11 As demonstrated in this study, this effect is exacerbated after AngII infusion; chronic infusion of AngII enhanced the release of versikine in murine aortas. In AngII-treated Adamts5
Δcat mice, immunoblotting revealed a marked reduction of the ADAMTS-specific DPEAAE neoepitope demonstrating the importance of ADAMTS-5 for versican cleavage. Versikine has been suggested to stimulate SMC migration and induce cell apoptosis during development. 33, 34 Little residual ADAMTS activity was detectable in aortas of AngII-treated Adamts5
Δcat mice. The latter is most likely attributable to ADAMTS-1, which was increased in Adamts5
Δcat mice. ADAMTS-1 is known to be processed into 2 active forms: (1) an ECM associated and (2) a soluble form, generated after MMP cleavage of the thrombospondin domain at the C terminus. The loss of ADAMTS-5 activity led to a rise in the soluble form of ADAMTS-1, and this effect was exacerbated after AngII treatment. The removal of the last thrombospondin domain renders ADAMTS-1 more similar to ADAMTS-5, suggesting that the release of soluble ADAMTS-1 could be a compensatory response to the loss of ADAMTS-5. ADAMTS-1, however, does not seem to be sufficient to compensate for the lack of ADAMTS-5 activity, at least with regards to versican cleavage.
Effects on TGF-β
The increase in total versican levels was associated with a concomitant upregulation of TGF-β in Adamts5
Δcat mice after AngII treatment. TGF-β is known to induce the expression of different proteoglycans, including versican. 23 In line with this finding, stimulation of arterial SMCs with TGF-β1 led to an increase in versican expression. Interestingly, it has also been shown that the latent form of TGF-β can be associated and subsequently activated by the C-terminal region of ADAMTS-1, thereby enhancing the inflammatory response in liver fibrosis. 35 In agreement with these results, we found a direct correlation between ADAMTS-1 and TGF-β regulation in ADAMTS-5
Δcat mice on AngII treatment. The increased levels of versican, TGF-β, and ADAMTS-1 were accompanied by an increased aortic dilatation in these mice after AngII treatment. Dysregulation of TGF-β has been linked to aneurysm development. 36, 37 However, the mechanisms of TGF-β-mediated aneurysm formation have not completely elucidated yet. The present study highlights an effect of ADAMTS activity on TGF-β bioavailability.
Regulation by LRP1
LRP1 has previously been implicated in aortic aneurysm formation in humans and mice 14, 38, 39 ; however, the exact mechanisms are unclear. LRP1 is involved in different cellular processes, such as lipid homeostasis, signal transduction, and endocytosis. 40, 41 LRP1 also acts as a protease sink responsible for cellular uptake of ADAMTS-5 from the extracellular space. 42 Moreover, LRP1 can bind TGF-β1 and TGF-β2 and thereby inhibit cell proliferation and regulate vascular remodeling, respectively. 43 After AngII treatment, LRP1 was less abundant in aortas of Adamts5
Δcat mice. This was accompanied by an increase in the short soluble form of ADAMTS-1 as a possible mechanism to compensate for the lack of ADAMTS-5. This coordinated regulation is consistent with a feedback mechanism between ADAMTS-1 and LRP1 and a compensatory downregulation of LRP1 in Adamts5
Δcat mice to increase the extracellular availability of ADAMTS proteases.
Silencing LRP1 in human aortic SMCs reduced ADAMTS5 expression and resulted in a loss of ADAMTS-mediated versican cleavage. Again, this was accompanied by an increase of ADAMTS-1 in the conditioned media. These findings expand on a previous report that the deletion of Lrp1 expression in SMCs augmented AsAo dilatation in AngII-treated mice. 14 
Limitations of the Study
A mouse model of AngII infusion was used to study the effects of ADAMTS-5 on aortic dilatation, which may not recapitulate all aspects of human aneurysmal disease, in particular with regards to hemodynamics and mechanotransduction. 44, 45 Also, the relative importance of different members of the ADAMTS family may differ between species. In human aneurysmal disease, previous studies have shown increased protein and transcript levels of ADAMTS-1 and -4 in TAA. 10, 46 Consistent with our findings, a recent study reported decreased ADAMTS5 expression and increased deposition of proteoglycans, such as aggrecan and versican in human TAA. 8 Finally, changes in ADAMTS activity are likely to be associated with the proteolysis of other proteins apart from versican.
Conclusions
At present, the clinical management of aneurysms is hampered by our limited knowledge about the cause and pathogenetic mechanisms involved in the disease. Evidence is emerging that ECM processing by members of the ADAMTS protease family could play an important role in the progression of aortic dilatation. 3 The present study takes advantage of proteomics to define vascular substrates of ADAMTS proteases. LRP1, which has been involved in aneurysm pathology in both human and mice, seems to be linked to ADAMTS-5 and ADAMTS-5-mediated versican cleavage. In mice lacking ADAMTS-5 activity, AngII infusion results in decreased versicanolysis, an increase in full-length versican and TGF-β, but reduced LRP1 compared with wild-type controls. Mice lacking ADAMTS-5 activity also showed increased aortic dilatation in response to AngII infusion despite a lower blood pressure. A compensatory rise in ADAMTS-1 could not prevent aortic dilatation in Adamts5
Δcat mice, suggesting the greater relative importance of ADAMTS-5 in this context. Further studies are needed to explore the ADAMTS protease family as a target for therapeutic approaches aimed to reduce or halt dilatation of the aorta resulting in dissection. 
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ONLINE METHODS
In vitro metalloprotease digestion assay. Murine aortic specimens were dissected into smaller pieces and washed 5 times in ice-cold, 1X PBS. The tissue blocks were then mixed with 10 volumes metalloprotease reaction buffer (10mM CaCl 2 , 120mM NaCl and 50mM Trizma base, pH 7.5), which was either used neat (control) or supplemented with different concentrations (50-100pM) of recombinant proteins; murine ADAMTS-1 and murine ADAMTS-5, all purchased from R&D Systems. The samples were incubated for 24hrs at 37°C. Subsequently, the released proteins in the tissue supernatants were deglycosylated.
For protein deglycosylation, samples were resuspended in deglycosylation buffer (150mM NaCl, 50mM sodium acetate pH 6.8, 10mM EDTA) for 16hrs at 37°C containing a combination of enzymes for GAG-removal enzymes: chondroitinase ABC (1:100), endo-β1,4-galactosidase (1:500) and heparinase II (1:500). The deglycosylated proteins were separated by gel electrophoresis prior to digestion and LC-MS/MS. Technologies) . Proteins were silver-stained for visualization and gel lanes were cut into 10 consecutive pieces. All gel bands were subjected to in-gel digestion with trypsin using an Investigator ProGest (Digilab) robotic digestion system. Tryptic peptides were lyophilized, reconstituted with 0.05% TFA in 2%
Gel-LC-MS/MS
ACN and separated on a nanoflow LC system (Thermofisher Scientific, Ultimate 3000).
Peptides were eluted with a 40-min gradient (10-25% B in 35min, 25-40% B in 5min, 90% B in 10min, and 2%B in 30min where A is 2% ACN, 0.1% formic acid in HPLC H 2 O and B is 90% ACN, 0.1% formic acid in HPLC H 2 O). The column (Thermofisher Scientific, PepMap C18, 25cm length, 75μm internal diameter, 3μm particle size) was coupled to a nanospray source (Picoview). Spectra were collected from an Orbitrap mass analyzer (LTQ-Orbitrap XL, ThermoFisher Scientific) using full ion scan mode over the mass-to-charge (m/z) range 450-1600. MS/MS was performed on the top six ions in each MS scan using the datadependent acquisition mode with dynamic exclusion enabled. MS/MS peak lists were generated by extract_msn.exe and matched to a mouse database (SwissProt_57.15, 16230
protein entries) using Mascot (version 2.3.01, Matrix Science). Carbamidomethylation of cysteine was chosen as a fixed modification and oxidation of methionine, lysine and proline were chosen as a variable modifications. The mass tolerance was set at 10ppm for the precursor ions and 0.8Da for fragment ions. Up to two missed cleavages were allowed.
Scaffold (version 3.0.08, Proteome Software Inc., Portland, OR) was used to calculate the spectral counts and to validate MS/MS-based peptide and protein identifications. Peptide identifications were accepted if they could be established at greater than 95.0% probability.
Protein identifications were accepted if they could be established at a minimum of 99.0%
probability.
ECM protein extraction. Diced tissue was weighed (8-12mg) and immediately placed into Eppendorf tubes containing 1 ml of ice-cold PBS supplemented with 1:100 (v:v) of a broad-spectrum protease inhibitor cocktail (Sigma-Aldrich), and 25mM EDTA to ensure inhibition of metalloproteinases. After 5 washes with PBS buffer the diced samples were incubated with a 0.5M NaCl buffer supplemented with 10mM Tris at pH 7.5, 1:100 (v:v) of a proteinase inhibitor cocktail and 25mM EDTA. The volume of the buffer was adjusted to 5:1 (v:w). Samples were mildly vortexed for 2hrs at room temperature (RT) to solubilize loosely bound ECM and ECM-associated proteins, after which the NaCl buffer was collected and frozen for later use. Samples were washed briefly in the PBS buffer, followed by incubation with 0.08% sodium dodecyl sulphate (SDS) supplemented with proteinase inhibitor cocktail and 25mM EDTA (same ratios as for NaCl buffer above). Samples were mildly vortexed for 2hrs at RT to achieve removal of cellular components, taking particular care to ensure a low vortexing speed to avoid mechanical disruption of the ECM. SDS extracts were then collected and frozen for later use. The tissue samples were washed briefly with water.
Finally, the samples were incubated in 4M guanidine hydrochloride buffer (GuHCl)
supplemented with 50mM sodium acetate at pH 5. This enzyme cleaves all asparagine-linked oligosaccharides unless α1,3-core fucosylated.
Importantly, asparagine must be peptide-bonded at both termini. After the first incubation step, water was evaporated from the extracts and substituted for an equal amount of H2 Material. The following day, after three washes in PBST (15min each), the membranes were incubated for 1h at RT with the HRP-conjugated secondary antibody diluted in 5% milk in PBST, according to the source of the primary antibody. The membranes were then washed three times in PBST for 15min and developed using ECL western blotting detection reagent using either X-ray films (FUJIFILM) or Chemidoc Touch, Imaging System (BIORAD).
Immunoblots were quantified by densitometry using Image-J software.
RNA isolation. RNA extraction was performed using the miRNeasy Mini Kit (Qiagen)
following the manufacturers' protocol. For aortic tissue, samples were diced using a scalpel, incubated in 700μl of Qiazol Lysis Reagent and homogenised using FastPrep ceramic lysis beads (Matrix D, MPBio). Cells were washed twice in cold sterile PBS and lysed in 700μl of Qiazol Lysis Reagent. Samples were subsequently incubated at RT for 5min, and then vortexed with 140μl of chloroform. The lysate was then incubated for a further 5min at RT before being centrifuged for 15min at 12,000 g, at 4°C. 280μl of the upper aqueous phase were transferred to a new tube, mixed with 1.5 volumes of 100% ethanol and transferred into a miRNeasy mini column. The remaining centrifugation steps were carried out at RT. The column was centrifuged for 1min at 12,000 g and the flow through was discarded, next 700μl
of RWT buffer was added to the column, centrifuged for 1min at 12,000 g and the flow through was discarded. Next, 500μl of RPE buffer were added to the column before a further centrifugation step for 1min at 12,000 g. The flow through was discarded and a further 500μl
of RPE buffer were added to the column before it was centrifuged at 12,000 g for 2min. The columns were transferred to clean collection tubes and centrifuged at 15,000 g for 1min,
before being transferred to a new tube. The RNA was eluted with 30μl of RNase-free water, by centrifugation at 10,000 g for 1min. RNA concentration (Abs 260nm) and purity (260/280)
were measured in 1μl using spectrophotometry (NanoDrop ND-1000, ThermoScientific).
Integrity of RNA was evaluated using Agilent Bioanalyser System. RNA quality was considered acceptable if the RNA integrity number (RIN) was above 7.
Reverse transcription (RT) and quantitative real-time PCR (qPCR).
The RNA was reverse-transcribed using random hexamers with SuperScript VILO MasterMix (Invitrogen)
according to manufacturers' protocol, with sample preparation being performed on a
StarChill PCR rack to maintain low temperature. RNA concentration of samples was adjusted to contain equal amounts of RNA (250-500ng) in 8μl using RNase-free water. No
DNase treatment was performed. The reverse transcription reaction was set up by mixing the 8μl of RNA with 2μl of SuperScript VILO MasterMix. RT reaction was performed in a Veriti thermal cycler (Applied Biosystems) with the following protocol: incubation at 25°C for 10min followed by 2hrs incubation at 42°C. the reaction was terminated by incubation at 85°C for 5min. Samples were kept at 4°C for immediate use in the qPCR reaction or stored at -20°C.
The RT product was diluted 1:15 to 1:25 using RNase-free water. TaqMan assays using hydrolysis probes (Major Resources Tables) were used for quantitative PCR (qPCR).
2.25μl of diluted RT product were combined with 2.5μl of TaqMan Universal PCR Master Mix, no AmpErase UNG (Applied Biosystems), 0.25μl of TaqMan assays on a MicroAmp
Optical 384-well reaction plate, using a Bravo Liquid Handling Platform (Agilent). qPCR reaction was performed in a ViiA 7 Real-Time PCR System (Applied Biosystems), set to run as follows: incubation at 95°C for 10min, followed by 40 cycles of 95°C for 15sec and 60°C for 1min. Data was analysed using ViiA 7 software (Applied Biosystems). A minimum of two reference genes was used throughout the study and stability of RNA isolation, RT and qPCR was determined by variability of and correlation between reference genes. Relative amounts of the targets were calculated using the 2 -∆∆Cq method, 17 with statistical analysis performed on ∆Cq values. 
